Connecticut SB 737: AN ACT CONCERNING PRESCRIPTION DRUG COST TRANSPARENCY.

Status: REF. TO JOINT COMM. ON General Law (as of 2017-01-26)

State: Connecticut · Session: 2017 · Bill: SB 737

Subjects: Drugs, Medical expenses, Pharmaceutical manufacturing companies

Sponsors: b'Kennedy, Ted'

View Connecticut SB 737 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.